Correlation Between Affimed NV and Rigel Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Affimed NV and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Affimed NV and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Affimed NV and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Affimed NV and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Affimed NV with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Affimed NV and Rigel Pharmaceuticals.

Diversification Opportunities for Affimed NV and Rigel Pharmaceuticals

-0.54

Correlation Coefficient

Affimed NV  Rigel Pharmaceuticals

Excellent diversification

The 3 months correlation between Affimed and Rigel is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Affimed NV and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Affimed NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Affimed NV are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Affimed NV i.e., Affimed NV and Rigel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Affimed NV and Rigel Pharmaceuticals

Given the investment horizon of 90 days Affimed NV is expected to under-perform the Rigel Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Affimed NV is 1.63 times less risky than Rigel Pharmaceuticals. The stock trades about -0.14 of its potential returns per unit of risk. The Rigel Pharmaceuticals is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  1,341  in Rigel Pharmaceuticals on September 5, 2024 and sell it today you would earn a total of  1,364  from holding Rigel Pharmaceuticals or generate 101.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Affimed NV  vs.  Rigel Pharmaceuticals

Affimed NV

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Affimed NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Rigel Pharmaceuticals

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting technical and fundamental indicators, Rigel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Affimed NV and Rigel Pharmaceuticals

The main advantage of trading using opposite Affimed NV and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Affimed NV position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.

The idea behind Affimed NV and Rigel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..